Evidence map›Paper›PMID 42311265›Full record

ArticleFrontiers in oncology2026

Leveraging deep learning and explainable AI for effective liver tumor classification from CT scan images.

Meshal Alfarhood, Shatha Alotaibi, Aows Abuhaimed, Abdalrahman Alalwan

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meshal AlfarhoodDepartment of Computer Science, College of Computer and Information Sciences, King Saud University, Riyadh, Saudi Arabia.
Shatha AlotaibiDepartment of Computer Science, College of Computer and Information Sciences, King Saud University, Riyadh, Saudi Arabia.
Aows AbuhaimedDepartment of Computer Science, College of Computer and Information Sciences, King Saud University, Riyadh, Saudi Arabia.
Abdalrahman AlalwanDepartment of Computer Science, College of Computer and Information Sciences, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cancer remains one of the leading causes of mortality worldwide, with 19.3 million new cases and 10 million deaths reported in 2020. According to the World Cancer Research Fund International (WCRF), liver cancer ranks as the fifth most prevalent cancer in men and the ninth in women. Despite available interventions, liver cancer is often diagnosed at advanced stages due to its subtle progression and the complexity of distinguishing hepatic malignancies from surrounding tissues in CT scans. Conventional diagnostic practices, such as biopsy, are invasive, time-consuming, and mentally exhausting for patients, while manual interpretation of CT images is labor-intensive and requires expert radiologists. These challenges highlight the urgent need for automated, accurate, and explainable diagnostic tools. Methods: In this work, we propose a comprehensive deep learning framework for non-invasive liver tumor classification with integrated explainability. We evaluated and fine-tuned several state-of-the-art supervised models, including ResNet50-v2, EfficientNetV2, Inception-v3, and Vision Transformer ViT-16, combined with tailored pre-processing and augmentation strategies. Results and discussion: The EfficientNetV2 model achieved 96.97% accuracy, demonstrating competitive performance with existing literature. Beyond high accuracy, the framework integrates explainable AI methods to enhance interpretability and clinical trust, bridging a key gap in current AI-driven liver cancer research.

Indexed as

classificationdeep learningexplainable artificial intelligenceliver cancerliver tumors

Identifiers

PMID42311265
PMCPMC13268880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.